Beatrice Razzo

@ZanwarSaurabh @AlGarfall Echoing our thanks, Saurabh!

@AlGarfall @BeaRazzo It is a fantastic and much needed study! Congratulations!

#ASH25 delivered 1,000+ myeloma abstracts—and we had the impossible task of picking the very best. Innovation came in every flavor: LIMITEC (@AlGarfall @BeaRazzo) testing “less is more,” AI to detect amyloid a decade early, in-vivo & dual-target CARs, and early bispecific combinations (Manier et al.) in the elderly. From the show-stopping MAJESTEC-3 data by @mvmateos to the sobering delayed neurotoxicity signal with CAR-T from @SurbhiSidanaMD —here are the 2025 #Myeloma Golden Globules for #ASHNewsDaily 🏆 bit.ly/4qhsXar @ASH_hematology @EmperorBlackMD @JoselleCookMD #mmsm

Fun breakfast with our LimiTec investigators this AM at #ASH25! Come see our results with limited-duration (6-9 months) teclistamab for RR #mmsm at poster 5814 tonight by @BeaRazzo. @rajshekharucms @hiragss @BloodCancerUtd @MyelomaTeacher

I am the patient research advocate on the Limitec Trial. @ Dr. @BeaRazzo and I just recorded a video for @HealthTree on the interim results. Stop by tonight’s poster session and look for Poster 5814. #mmsm #ASH25